• 医学文献
  • 知识库
  • 评价分析
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
  • 临床诊疗知识库
  • 中医药知识库
  • 机构
  • 作者
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

医学文献>>
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
热搜词:
换一批

MiR-125b-1-3p Exerts Antitumor Functions in Lung Carcinoma Cells by Targeting S1PR1

摘要Background:MicroRNAs (miRNAs) have been extensively studied over the decades and have been identified as potential molecular targets for cancer therapy.To date,many miRNAs have been found participating in the tumorigenesis of non-small cell lung cancer (NSCLC).The present study was designed to evaluate the functions of miR-125b-l-3p in NSCLC cells.Methods:MiR-125b-l-3p expression was detected in tissue samples from 21 NSCLC patients and in NSCLC cell lines using the real-time polymerase chain reaction.A549 cell lines were transfected with a miR-125b-1-3p mimic or miR-125b-1-3p antisense.Cell counting kit-8,wound healing,Matrigel invasion assays,and flow cytometry were used to assess the effects of these transfections on cell growth,migration,invasion,and apoptosis,respectively.Western blotting was used to detect apoptosis-related proteins,expression ofS 1PR1,and the phosphorylation status of STAT3.Significant differences between groups were estimated using Student's t-test or a one-way analysis of variance.Results:MiR-125b-1-3p was downregulated in NSCLC samples and cell lines.Overexpression of miR-125b-1-3p inhibited NSCLC cell proliferation (37.8 ± 9.1%,t =3.191,P =0.013),migration (42.3 ± 6.7%,t =6.321,P =0.003),and invasion (57.6 ± 11.3%,t =4.112,P =0.001) and simultaneously induced more NSCLC cell apoptosis (2.76 ± 0.78 folds,t =3.772,P =0.001).MiR-125b-1-3p antisense resulted in completely opposite results.S1PR1 was found as the target gene ofmiR-125b-1-3p.Overexpression ofmiR-125b-1-3p inhibited S 1PR1 protein expression (27.4 ± 6.1% of control,t =4.083,P =0.007).In addition,S1PR1 siRNA decreased STAT3 phosphorylation (16.4 ± 0.14% of control,t =3.023,P=0.015),as in cells overexpressing miR-125b-1-3p (16.7 ± 0.17% of control,t =4.162,P=0.026).Conclusion:Our results suggest that miR-125b-1-3p exerts antitumor functions in NSCLC cells by targeting S1PR1.

更多
广告
作者单位 Department of Thoracic Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325000, China [1]
栏目名称 Original Articles
DOI 10.4103/0366-6999.238135
发布时间 2018-09-10
基金项目
the grants from the Natural Science Foundation of Zhejiang Province Wenzhou Municipal Foundation of Science and Technology
提交
  • 浏览19
  • 下载8
中华医学杂志(英文版)

中华医学杂志(英文版)

2018年131卷16期

1909-1916页

SCIMEDLINEISTICCSCDCABP

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷